InTest Earnings Call Transcripts
Fiscal Year 2025
-
Q4 2025 saw strong revenue and margin growth, driven by diversification and new products, with a record backlog positioning the company for 2026 growth. Guidance anticipates 12% revenue growth in 2026, led by industrial, life sciences, and auto EV, while semi recovery is conservatively forecasted.
-
The business has doubled revenue in five years through diversification and innovation, with strong Q3 orders and a robust backlog. New product launches and global expansion support Vision 2030 growth targets, while automotive/EV and defense/aero markets are rebounding.
-
Q3 saw strong order growth in automotive and defense aerospace, but revenue declined due to shipment delays and ongoing semi market weakness. Backlog and liquidity improved, and Q4 revenue is expected to rebound to $30–$32 million as delayed shipments are fulfilled.
-
Q2 2025 saw $28.1M revenue and 42.6% gross margin, with strong order growth in auto EV, life sciences, and defense/aerospace, offsetting semiconductor weakness. Cost controls and debt reduction improved profitability, while new products and geographic expansion support long-term growth.
-
Q1 2025 saw revenue of $26.6M and a net loss of $2.3M, with growth in auto/EV and life sciences offsetting declines in semi and industrial. Tariff uncertainty and engineering delays impacted results, but cost controls and diversification efforts are supporting resilience.
-
Revenue nearly doubled since 2021, with a diversified portfolio and strong innovation pipeline. The 2030 vision targets $260 million revenue, 20% operating income, and 15%-20% service revenue, driven by organic growth, M&A, and operational excellence.
-
The company has executed a strategic transformation, diversifying beyond semi-test into automotive, industrial, and defense, supported by acquisitions and a five-point growth plan. Q3 2024 saw solid order growth and strong margins, with continued focus on M&A and organic expansion. Back-end semi is recovering, while other markets remain stable or strong.
Fiscal Year 2024
-
Record Q4 and full-year revenue driven by acquisitions and strong demand in targeted markets offset semi weakness. 2025 outlook is cautious due to tariff and market uncertainties, with revenue expected between $125–$135M and gradual profitability improvement.
-
Management highlighted ongoing diversification, robust growth in auto EV and defense, and improved gross margins despite softness in semi. The Alphamation acquisition strengthens European presence and technology portfolio. Full-year guidance was tightened, with a focus on organic growth and disciplined capital allocation.
-
Q3 revenue reached $30 million with strong gross margin expansion, driven by favorable product mix and cost actions, while diversified markets and Alphamation contributed to growth. Back end semiconductor demand improved, but front end remains weak, with recovery expected in late 2025.
-
Management outlined a five-point strategy driving diversification and growth, highlighted by the Alphamation acquisition, which is integrating well and expanding market reach. Q2 saw record revenue but lower margins, with full-year guidance reduced due to semi market softness.
-
Leadership transformation and a five-point strategy have driven diversification and global expansion, with recent acquisitions like Alfamation boosting auto EV and electronic test capabilities. Q2 saw record revenue but lower margins due to product mix, and full-year guidance was revised downward amid semiconductor and industrial softness.
-
Q2 2024 saw record revenue of $34M, driven by the Alfamation acquisition, offsetting ongoing semi market weakness. Gross margin declined to 40.6%, and cost-saving actions are underway. 2024 revenue is now guided at $128–133M, with subdued front-end semi demand expected into 2025.